Previous Page  8 / 18 Next Page
Information
Show Menu
Previous Page 8 / 18 Next Page
Page Background

Page 87

conferenceseries

.com

Volume 8, Issue 1 (Suppl)

J Cell Sci Ther

ISSN: 2157-7013 JCEST, an open access journal

Stem Cell Research 2017

March 20-22, 2017

March 20-22, 2017 Orlando, USA

8

th

World Congress and Expo on

Cell & Stem Cell Research

Relationship between anesthetic-induced toxicity and NMDA receptor-mediated calcium influx in

developing neurons

Cheng Wang, Fang Liu, Tucker A Patterson, Merle G Paule and William Slikker

National Center for Toxicological Research/Food and Drug Administration, USA

K

etamine is a non-competitive NMDA receptor antagonist and is used as a general anesthetic. Recent data suggest that anesthetics

can cause neuronal damage when exposure occurs during development. To elucidate the underlying mechanisms associated

with ketamine neurotoxicity, neural cells were harvested from the forebrain of newborn rats and neural stem cells were isolated

from gestational day-16 rats. To determine the effect of ketamine on developing neurons and undifferentiated neural stem cells,

cultures were exposed to 10 µM ketamine for 24 hours. Ketamine exposure resulted in elevated NMDA receptor (NR1) expression in

primary cultures, and enhanced damage of developing neurons including those differentiated from the neural stem cells. However,

the viability and proliferation rate of neural stem cells were not significantly affected after ketamine exposure. Calcium imaging

data indicated that 50 µM NMDA did not cause a significant influx of calcium in typical neural stem cells; however, it has produced

an immediate elevation of intracellular free Ca2

+

[Ca

2+

]i in neurons differentiated from the same neural stem cells. These findings

suggest that prolonged exposure of developing neurons to ketamine produces an increase in NMDA receptor expression, which

allows for a higher/toxic influx of calcium into neurons once ketamine is removed from the system, leading to neuronal cell death

likely due to elevated reactive oxygen species generation.

cheng.Wang@fda.hhs.gov

J Cell Sci Ther 2017, 8:1 (Suppl)

http://dx.doi.org/10.4172/2157-7013.C1.039